The Oncosearch | Oncotarget

Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer Research Paper

Aida Barreiro-Alonso, MÃ³nica Lamas-Maceiras, Rosa GarcÃa-DÃaz, Esther RodrÃguez-Belmonte, Lu Yu, Mercedes Pardo, Jyoti S. Choudhary, MarÃa Esperanza CerdÃ¡n

Published Apr 10, 2018 · Vol. 9, No. 27 · pp. 19050-19064

Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer Research Paper

Amanda O. Salzwedel, Joohee Han, Christopher J. LaRocca, Ryan Shanley, Masato Yamamoto, Julia Davydova

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18041-18052

Heteronemin, a marine natural product, sensitizes acute myeloid leukemia cells towards cytarabine chemotherapy by regulating farnesylation of Ras Research Paper

Minakshi Saikia, Archana P. Retnakumari, Shabna Anwar, Nikhil P. Anto, Rashmi Mittal, Shabna Shah, Kavya S. Pillai, Vinod S. Balachandran, Vidya Peter, Reeba Thomas, Ruby John Anto

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18115-18127

Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer Research Paper

Adriana Harbuzariu, Ruben Rene Gonzalez-Perez

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18239-18253

Increased gut permeability in cancer cachexia: mechanisms and clinical relevance Research Paper

Laure B. Bindels, Audrey M. Neyrinck, Audrey Loumaye, Emilie Catry, Hannah Walgrave, Claire Cherbuy, Sophie Leclercq, Matthias Van Hul, Hubert Plovier, Barbara Pachikian, Luis G. BermÃºdez-HumarÃ¡n, Philippe Langella, Patrice D. Cani, Jean-Paul Thissen, Nathalie M. Delzenne

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18224-18238

A TRPV2 interactome-based signature for prognosis in glioblastoma patients Research Paper

Pau DoÃ±ate-MaciÃ¡n, Antonio GÃ³mez, Irene R. DÃ©gano, Alex PerÃ¡lvarez-MarÃn

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18400-18409

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma Research Paper

Jaine K. Blayney, Lauren Cairns, Gerald Li, Niamh McCabe, Leanne Stevenson, Christopher J. Peters, Nathan B. Reid, Veronica J. Spence, Chintapuza Chisambo, Damian McManus, Jacqueline James, Stephen McQuaid, Stephanie Craig, Kenneth Arthur, Darragh McArt, Chin-Ann J. Ong, Pierre Lao-Sirieix, Peter Hamilton, Manuel Salto-Tellez, Martin Eatock, Helen G. Coleman, Rebecca C. Fitzgerald, Richard D. Kennedy, Richard C. Turkington, On behalf of the Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Study Group

Published Apr 6, 2018 · Vol. 9, No. 26 · pp. 18518-18528

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting Research Paper

Neja Samec, Ivana Jovcevska, Jure Stojan, Alja Zottel, Mirjana Liovic, Michael P. Myers, Serge Muyldermans, Jernej Å ribar, Igor KriÅ¾aj, Radovan Komel

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17282-17299

Microbiota effects on cancer: from risks to therapies Review

Domenica Rea, Giovanni Coppola, Giuseppe Palma, Antonio Barbieri, Antonio Luciano, Paola Del Prete, Sabrina Rossetti, Massimiliano Berretta, Gaetano Facchini, Sisto PerdonÃ, Maria Caterina Turco, Claudio Arra

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17915-17927

Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC) Research Paper

Silvia Vecchiarelli, Francesco Passiglia, Armida Dâ€™Incecco, Marianna Gallo, Antonella De Luca, Elisa Rossi, Federica Dâ€™IncÃ, Gabriele Minuti, Lorenza Landi, Chiara Bennati, Michela Spreafico, Manolo Dâ€™Arcangelo, Valentina Mazza, Nicola Normanno, Federico Cappuzzo

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17554-17563

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells Research Paper

Erminia Romano, Nicole Rufo, Hannelie Korf, Chantal Mathieu, Abhishek D. Garg, Patrizia Agostinis

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17631-17644

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer Research Paper

Agnieszka Dansonka-Mieszkowska, Lukasz M. Szafron, Joanna Moes-Sosnowska, Mariusz Kulinczak, Anna Balcerak, Bozena Konopka, Magdalena Kulesza, Agnieszka Budzilowska, Martyna Lukasik, Urszula Piekarska, Iwona K. Rzepecka, Joanna Parada, Renata Zub, Barbara Pienkowska-Grela, Radoslaw Madry, Jan K. Siwicki, Jolanta Kupryjanczyk

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17735-17755

CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan Research Paper

Yasuyuki Shigematsu, Kentaro Inamura, Yoshihiro Mise, Akio Saiura, Emil Rehnberg, Noriko Yamamoto, Yuichi Ishikawa, Shunji Takahashi, Hiroaki Kanda

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17056-17065

Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy Research Paper

Nagendra K. Chaturvedi, Matthew J. Kling, Don W. Coulter, Timothy R. McGuire, Sutapa Ray, Varun Kesherwani, Shantaram S. Joshi, J. Graham Sharp

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16619-16633

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells Research Paper

Daniela Catanzaro, Silvia Nicolosi, Veronica Cocetta, Marika Salvalaio, Andrea Pagetta, Eugenio Ragazzi, Monica Montopoli, Gianfranco Pasut

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16847-16860

ATM/RB1 mutations predict shorter overall survival in urothelial cancer Research Paper

Ming Yin, Petros Grivas, Hamid Emamekhoo, Prateek Mendiratta, Siraj Ali, JoAnn Hsu, Monali Vasekar, Joseph J. Drabick, Sumanta Pal, Monika Joshi

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16891-16898

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer Research Paper

Cathy B. Moelans, Caroline M.G. van Maldegem, Elsken van der Wall, Paul J. van Diest

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17078-17092

Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer Research Paper

Emily Chan, Rodney Luwor, Christopher Burns, George Kannourakis, Jock K. Findlay, Nuzhat Ahmed

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16599-16618

¹⁸FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients Research Paper

Patricia de Cremoux, Lucie Biard, Brigitte Poirot, Philippe Bertheau, Luis Teixeira, Jacqueline Lehmann-Che, Fatiha A. Bouhidel, Pascal Merlet, Marc EspiÃ©, Matthieu Resche-Rigon, Christos Sotiriou, David Groheux

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16343-16353

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer Research Paper

Francesca Toffalorio, Mariacarmela Santarpia, Davide Radice, Christopher Adrian Jaramillo, Gianluca Spitaleri, Michela Manzotti, Chiara Catania, Lars Petter Jordheim, Giuseppe Pelosi, Godefridus J. Peters, Carmelo Tibaldi, Niccola Funel, Lorenzo Spaggiari, Filippo de Braud, Tommaso De Pas, Elisa Giovannetti

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16437-16450

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer Research Paper

Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer Research Paper

Heteronemin, a marine natural product, sensitizes acute myeloid leukemia cells towards cytarabine chemotherapy by regulating farnesylation of Ras Research Paper

Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer Research Paper

Increased gut permeability in cancer cachexia: mechanisms and clinical relevance Research Paper

A TRPV2 interactome-based signature for prognosis in glioblastoma patients Research Paper

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma Research Paper

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting Research Paper

Microbiota effects on cancer: from risks to therapies Review

Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC) Research Paper

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells Research Paper

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer Research Paper

CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan Research Paper

Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy Research Paper

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells Research Paper

ATM/RB1 mutations predict shorter overall survival in urothelial cancer Research Paper

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer Research Paper

Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer Research Paper

¹⁸FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients Research Paper

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer Research Paper

Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer Research Paper

Heteronemin, a marine natural product, sensitizes acute myeloid leukemia cells towards cytarabine chemotherapy by regulating farnesylation of Ras Research Paper

Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer Research Paper

Increased gut permeability in cancer cachexia: mechanisms and clinical relevance Research Paper

A TRPV2 interactome-based signature for prognosis in glioblastoma patients Research Paper

Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma Research Paper

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting Research Paper

Microbiota effects on cancer: from risks to therapies Review

Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC) Research Paper

BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells Research Paper

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer Research Paper

CDX2 expression is concordant between primary colorectal cancer lesions and corresponding liver metastases independent of chemotherapy: a single-center retrospective study in Japan Research Paper

Improved therapy for medulloblastoma: targeting hedgehog and PI3K-mTOR signaling pathways in combination with chemotherapy Research Paper

Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells Research Paper

ATM/RB1 mutations predict shorter overall survival in urothelial cancer Research Paper

Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer Research Paper

Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer Research Paper

18FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients Research Paper

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer Research Paper

¹⁸FDG-PET/CT and molecular markers to predict response to neoadjuvant chemotherapy and outcome in HER2-negative advanced luminal breast cancers patients Research Paper